A detailed history of Northern Trust Corp transactions in Pulmonx Corp stock. As of the latest transaction made, Northern Trust Corp holds 328,322 shares of LUNG stock, worth $2.08 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
328,322
Previous 335,257 2.07%
Holding current value
$2.08 Million
Previous $4.27 Million 28.8%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$8.71 - $14.65 $60,403 - $101,597
-6,935 Reduced 2.07%
328,322 $3.04 Million
Q4 2023

Feb 13, 2024

SELL
$7.89 - $13.14 $150,430 - $250,527
-19,066 Reduced 5.38%
335,257 $4.27 Million
Q3 2023

Nov 13, 2023

BUY
$9.88 - $14.0 $65,138 - $92,302
6,593 Added 1.9%
354,323 $3.66 Million
Q2 2023

Aug 11, 2023

BUY
$10.78 - $13.65 $285,831 - $361,929
26,515 Added 8.25%
347,730 $4.56 Million
Q1 2023

May 15, 2023

BUY
$7.49 - $12.54 $34,768 - $58,210
4,642 Added 1.47%
321,215 $3.59 Million
Q4 2022

Feb 13, 2023

BUY
$4.92 - $17.35 $33,052 - $116,557
6,718 Added 2.17%
316,573 $2.67 Million
Q3 2022

Nov 14, 2022

BUY
$15.35 - $23.99 $83,580 - $130,625
5,445 Added 1.79%
309,855 $5.16 Million
Q2 2022

Aug 12, 2022

BUY
$14.0 - $27.95 $639,576 - $1.28 Million
45,684 Added 17.66%
304,410 $4.48 Million
Q1 2022

May 13, 2022

SELL
$21.13 - $35.65 $218,653 - $368,906
-10,348 Reduced 3.85%
258,726 $6.42 Million
Q4 2021

Feb 08, 2022

BUY
$29.72 - $45.1 $52,544 - $79,736
1,768 Added 0.66%
269,074 $8.63 Million
Q3 2021

Nov 15, 2021

BUY
$35.98 - $44.48 $1.36 Million - $1.68 Million
37,777 Added 16.46%
267,306 $9.62 Million
Q2 2021

Aug 13, 2021

BUY
$37.61 - $48.0 $3.98 Million - $5.08 Million
105,917 Added 85.69%
229,529 $10.1 Million
Q1 2021

May 12, 2021

SELL
$44.0 - $67.54 $352,396 - $540,927
-8,009 Reduced 6.08%
123,612 $5.65 Million
Q4 2020

Feb 11, 2021

BUY
$39.31 - $69.02 $5.17 Million - $9.08 Million
131,621 New
131,621 $9.09 Million

Others Institutions Holding LUNG

About Pulmonx Corp


  • Ticker LUNG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,268,400
  • Market Cap $236M
  • Description
  • Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...
More about LUNG
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.